Modulation of G protein-coupled receptors by an estrogen receptor that activates protein kinase A

Molecular Pharmacology

Volumn 51, Issue 4, 1997, Pages 605-612

  Lagrange, Andre H ^a   Rønnekleiv, Oline K ^a   Kelly, Martin J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; ESTROGEN RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; NALOXONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; EFFECTOR CELL; ENZYME ACTIVATION; GUINEA PIG; HYPERPOLARIZATION; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RECEPTOR AFFINITY; SYNAPTIC TRANSMISSION;

EID: 0030978296     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.51.4.605     Document Type: Article

References (40)

1. O'Malley, B. W., and M.-J. Tsai. Molecular pathways of steroid receptor action. Biol. Repro. 46:163-167 (1992).
2. Church, C. J., P. J. Kushner, and G. L. Greene. The interaction of human estrogen receptor with DNA is modulated by receptor-associated proteins. Mol. Endocrinol. 8:1407-1419 (1994).
3. Smith, C. L., O. M. Conneely, and B. W. O'Malley. Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone. Proc. Natl. Acad. Sci. USA 90:6120-6124 (1993).
4. Skipper, J. K., L. J. Young, J. M. Bergerson, M. T. Tetzlaff, C. T. Osborn, and D. Crews Identification of an isoform of the estrogen receptor mes senger RNA lacking exon four and present in the brain. Proc. Natl. Acad. Sci. USA 90:7172-7175 (1993).
5. Towle, A. C., and P. Y. Sze. Steroid binding to synaptic plasma membrane: differential binding of glucocorticoids and gonadal steroids. J. Steroid Biochem. Mol. Biol. 18:135-143 (1983).
6. Mellon, S. H. Neurosteroids: biochemistry, modes of action, and clinical relevance. J. Clin. Endocr. Metab. 78:1003-1008 (1994).
7. Tesarik, J., and C. Mendoza. Nongenomic effects of 17β-estradiol on maturing human oocytes: relationship to oocyte developmental potential. J. Clin. Endocr. Metab. 80:1438-1443 (1995).
8. Minami, T., Y. Oomura, J. Nabekura, and A. Fukuda. 17β-Estradiol depolarization of hypothalamic neurons is mediated by cyclic AMP. Brain Res. 519:301-307 (1990).
9. Aronica, S. M., W. L. Kraus, and B. S. Katzenellenbogen. Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc. Natl. Acad. Sci. USA 91:8517-8521 (1994).
10. Matsuda, S., Y. Kadowaki, M. Ichino, T. Akiyama, K. Toyoshima, and T. Yamamoto 17β-Estradiol mimics ligand activity of the c-erbB2 protooncogene product. Proc. Natl. Acad. Sci. USA 90:10803-10807 (1993).
11. Mermelstein, P. G., J. B. Becker, and D. J. Surmeier. Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. J. Neurosci. 16:595-604 (1996).
12. Yamaji, T., D. J. Dierschke, and A. N. Bhattacharya. The negative feedback control by estradiol and progesterone of LH secretion in the ovariectomized rhesus monkey. Endocrinology 90:771-777 (1972).
13. Condon, T. P., M. A. Dykshoorn-Bosch, and M. J. Kelly. Episodic LH release in the ovariectomized guinea pig: rapid inhibition by estrogen. Biol. Repro. 38:121-126 (1988).
14. Sarkar, D. K., and G. Fink. Luteinizing hormone releasing factor in pituitary stalk plasma from long-term ovariectomized rats: effects of steroids. J. Endocrinol. 86:511-524 (1980).
15. Ferin, M. D. Van Vugt, and S. Wardlaw. The hypothalamic control of the menstrual cycle and the role of endogenous opioid peptides. Recent Prog. Horm. Res. 40:441-485 (1984).
16. Goldstein, A., and A. Naidu. Multiple opioid receptors. ligand selectivity profiles and binding site signatures. Mol. Pharmacol. 36:265-272 (1989).
17. Lagrange, A. H., O. K. Rønnekleiv, and M. J. Kelly. Estradiol-17β and μ-opioid peptides rapidly hyperpolarize GnRH neurons: a cellular mechanism of negative feedback? Endocrinology 136:2341-2344 (1995).
18. Lagrange, A. H., O. K. Rønnekleiv, and M. J. Kelly. The potency of μ-opioid hyperpolarization of hypothalamic arcuate neurons is rapidly attenuated by 17β-estradiol. J. Neurosci. 14:6196-6204 (1994).
19. i1, a GTP-binding protein in reconstituted lipid vesicles. Neurosci. Lett. 113:47-49 (1990).
20. Schild, H. O. pA: a new scale for the measurement of drug antagonism. Br. J. Pharmacol. 2:189-206 (1947).
21. Rønnekleiv, O. K., M. D. Loose, K. R. Erickson, and M. J. Kelly. A method for immunocytochemical identification of biocytin-labeled neurons following intracellular recording. Biotechniques 9:432-438 (1990).
22. Schwarz, S., and P. Pohl. Steroids and opioid receptors. J. Steroid Biochem. Mol. Biol. 48:391-402 (1994).
23. 2 and receptor differentiation: a statistical analysis of competitive antagonism. Life Sci. 25:637-654 (1979).
24. Webb, P. G. N. Lopez, R. M. Uht, and P. J. Kushner. Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol. Endocrinol. 9:443-456 (1995).
25. Weatherill, P. J., A. P. M. Wilson, R. I. Nicholson, P. Davies, and A. E. Wakeling Interaction of the antioestrogen ICI 164,384 with the oestrogen receptor. J. Steroid Biochem. Mol. Biol. 30:263-266 (1988).
26. Barnea, A., and J. Gorski. Estrogen-induced protein: time course of synthesis. Biochemistry 9:1899-1904 (1970).
27. 1 pyramidal cell dendrites via a muscarinic, NMDA-dependent mechanism. J. Neurosci. 13:1010-1021 (1993).
28. Borras, M., L. Hardy, F. Lempereur, A. H. El Khissiin, N. Legros, R. Gol-Winkler, and G. Leclercq. Estradiol-induced down-regulation of estrogen receptor: effects of various modulators of protein synthesis and expression. J. Steroid Biochem. Mol. Biol. 48:325-336 (1994).
29. Gu, Q., and R. L. Moss. 17β-Estradiol potentiates kainate-induced currents via activation of the cAMP cascade. J. Neurosci. 16:3620-3629 (1996).
30. Van Haastert, P. J. M., R. Van Driel, B. Jastorff, J. Baraniak, W. J. Stec, and R. J. W. De Wit. Competitive cAMP antagonists for cAMP-receptor proteins. J. Biol. Chem. 259:10020-10024 (1984).
31. Kase, H., K. Iwahashi, S. Nakanishi, Y. Matsuda, K. Yamada, M. Takahashi, C. Murakata, A. Sato, and M. Kaneko. K-252 compounds: novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Commun. 142:436-440 (1987).
32. Christie, M. J., J. T. Williams, and R. A. North. Cellular mechanisms of opioid tolerance: studies in single brain neurons. Mol. Pharmacol. 32:633-638 (1987).
33. Nestler, E. J. Molecular neurobiology of drug addiction. Neuropsychopharmacology 11:77-87 (1994).
34. Kovoor, A., D. J. Henry, and C. Chavkin. Agonist-induced desensitization of the μ-opioid receptor-coupled potassium channel (GIRK1). J. Biol. Chem. 270:589-595 (1995).
35. Mestek A., J. H. Hurley, L. S. Bye, A. D. Campbell, Y. Chen, M. Tian, J. Liu, H. Schulman, and L. Yu. The human μ-opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. J. Neurosci. 15:2396-2406 (1995).
36. 2-adrenergic receptor by β-adrenergic receptor kinase, cAMP-dependent protein kinase, and protein kinase C occurs via distinct molecular mechanisms. Biochemistry 31:3193-3197 (1992).
37. Kelly, M. J., G. Zhang, A. H. Lagrange, and O. K. Rønnekleiv. Tolerance in hypothalamic β-endorphin neurons following chronic morphine. Regul. Pept. 54:145-146 (1994).
38. Lieberman, M. E., R. A. Maurer, and J. Gorski. Estrogen control of prolactin synthesis in vitro. Proc. Natl. Acad. Sci. USA 75:5946-5949 (1978).
39. Karsch, F. J. Central actions of ovarian steroids in the feedback regulation of pulsatile secretion of luteinizing hormone. Annu. Rev. Phys. 49:365-382 (1987).
40. B response in hypothalamic neurons. Neuroendocrinology 64:114-123 (1996).